1 Terry MB,Gaudet MM,Gammon MD.The epidemiology of gastric cancer[J].Semin Radiat Oncol,2002,12(5):111-127.
2 Ali Z,Deng Y.Progress of research in gastric cancer[J].J Nanosci Nanotechnol,2012,12(11)8241-8248.
3 Balkwill F,Mantovani A.Inflammation and cancer:back to Virchow[J].Lancet,2001,357(9255):539-545.
4 Ding SZ,Zheng PY.Helicobacter pylori infection induced gastric cancer;advance in gastric stem cell research and the remaining challenges[J].Gut Pathog,2012,4(1):18-21.
5 Flossmann E,Rothwell PM.Effect of aspirin on long-term risk of colorectal cancer:consistent evidence from randomised and observational studies[J].Lancet,2007,369(9573):1603-1613.
6 Xing F,Saidou J.Cancer associated fibroblasts(CAFs)in tumor microenvironment[J].Front Biosci,2010,15(4):166-179.
7 Peek RM,Crabtree JE.Helicobacter infection and gastric neoplasia[J].J Pathol,2006,208(2):233-248.
8 Wisastra R,Dekker FJ.Inflammation,cancer and oxidative lipoxygenase activity are intimately linked[J].Cancers(Basel),2014,6(3):1500-1521.
9 Liu XJ,Chen ZF.Interaction between cyclooxygenase-2,Snail,and E-cadherin in gastric cancer cells[J].World J Gastroenterol,2013,19(37):6265-6271.
10 Mantovani A,Allavena P.Cancer-related inflammation[J].Nature,2008,454(7203):436-444.
11 Karin M.Nuclear factor-kappaB in cancer development and progression[J].Nature,2006,441(7092):431-436.
12 吴红梅,齐蕾.肿瘤相关巨噬细胞与肿瘤关系的研究进展[J].实用肿瘤学杂志,2014,28(3):258-262.
13 Howlader N,Ries LA.Improved estimates of cancer-specific survival rates from population-based data[J].J Natl Cancer Inst,2010,102(20):1584-1598.
14 Kwon HC,Kim SH.Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patients[J].World J Gastroenterol,2012,18(34):4744-4750.
15 Crone SG,Jacobsen A.microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer[J].Mol Cancer,2012,11(9):71-75
16 何玉,蒋鸥.肿瘤相关巨噬细胞在胃癌中的研究进展[J].实用肿瘤学杂志,2014,28(3):272-275.
17 Tye H,Kennedy CL.STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation[J].Cancer Cell,2012,22(4):466-478.
18 Grávalos C,Gómez-Martín C.Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer[J].Clin Transl Oncol,2011,13(3):179-184.
19 Allavena P,Mantovani A.Immunology in the clinic review series;focus on cancer:tumour-associated macrophages:undisputed stars of the inflammatory tumour microenvironment[J].Clin Exp Immunol,2012,167(2):195-205.
20 Chua TC,Merrett ND.Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes-a systematic review[J].Int J Cancer,2012,130(12):2845-2856.
21 Lu X,Liu J,Li H.Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-β1[J].Surg Oncol,2011,104(6):571-577.
22 Schimanski CC,Schlaegel F.VEGF-D correlates with metastatic disease in gastric cancer patients undergoing surgery[J].World J Surg,2011,35(5):1010-1016.
23 Lee K,Hwang H.Immune response and the tumor microenvironment:how they communicate to regulate gastric cancer[J].Gut Liver,2014,8(2):131-139.
24 Semba S,Kodama Y.Direct cancer-stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells[J].Br J Cancer,2009,101(8):1365-1373.
25 Shigematsu Y,Niwa T.Interleukin-1β induced by Helicobacter pylori infection enhances mouse gastric carcinogenesis[J].Cancer Lett,2013,340(1):141-147.
26 Lee HJ,Song IC.CXC chemokines and chemokine receptors in gastric cancer[J].World J Gastroenterol,2014,20(7):1681-1693.
27 Qadri Q,Rasool R.Study of TLR4 and IL-8 gene polymorphisms in H.pylori-induced inflammation in gastric cancer[J].Immunol Invest,2014,43(4):324-336. |